Form 4 for BCDA BioCardia, Inc.
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0001437749-24-004265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-15 | 2024-02-13 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $0.46 | +108.1K | 555.4K | +24% | +$49.7K |
| D | 2024-02-15 | 2024-02-13 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | — | +54.1K | 121.5K | +80% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-13 | P | A | 108,108 | $0.46 | 555,447 | D | — | — | (F1) On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased. |
| 2 | Derivative | Warrant (right to buy | 2024-02-13 | P | A | 54,054 | — | 121,538 | D | $0.44 · 2024-02-13 to 2026-02-13 | 54,054 Common Stock | (F1) On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased. |